JBF Capital’s LAVA Therapeutics LVTX Stock Holding History

JBF Capital’s Portfolio LVTX Stock Details LVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23,911	Closed	-$37.3K	–	88
2025 Q3	$37.3K	Buy	+23,911	New	+$35.7K	0.01%	77

JBF Capital's LVTX Position: Q4 2025 in Review

JBF Capital sold out of LAVA Therapeutics (LVTX) in Q4 2025, closing a stake of 23,911 shares — an estimated $37.3K sold.

JBF Capital first reported a position in LVTX in Q3 2025 and held it in 1 quarter. The position peaked at $37.3K in Q3 2025. 0 funds tracked by Wall St. Rank hold LVTX as of Q4 2025.

JBF Capital reported no remaining LAVA Therapeutics position as of Q4 2025 after selling out during the quarter.
JBF Capital sold 23,911 LAVA Therapeutics shares in Q4 2025, an estimated $37.3K.
JBF Capital first reported a position in LAVA Therapeutics in Q3 2025 and held it in 1 quarter.
JBF Capital's LAVA Therapeutics position peaked at $37.3K in Q3 2025.
0 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2025.

Based on JBF Capital's 13F filing for Q4 2025, filed 12 Feb 2026.